首页 | 本学科首页   官方微博 | 高级检索  
     

血清PTX3联合Sestrin2对感染性休克患者疾病转归的预测效能
引用本文:符气鹏,陈羽,张杰,梁师国. 血清PTX3联合Sestrin2对感染性休克患者疾病转归的预测效能[J]. 中国现代医学杂志, 2024, 34(10): 78-83
作者姓名:符气鹏  陈羽  张杰  梁师国
作者单位:海口市人民医院(中南大学湘雅医学院附属海口医院)急诊科, 海南 海口 570208
基金项目:海南省自然科学基金青年基金(No:820QN405)
摘    要:目的 探讨血清正五聚蛋白3(PTX3)联合Sestrin2对感染性休克患者疾病转归的预测效能。方法选取2020年5月—2023年5月海口市人民医院收治的122例感染性休克患者作为研究组,连续随访28 d,根据预后生存情况分为存活组(83例)和死亡组(39例)。另取同期该院健康体检人群150例作为对照组。采用酶联免疫吸附试验检测血清PTX3、Sestrin2水平,受试者工作特性(ROC)曲线评估血清PTX3、Sestrin2对感染性休克患者预后的预测价值,多因素逐步Logistic回归模型探讨感染性休克患者预后的影响因素。结果 研究组血清PTX3、Sestrin2水平均高于对照组(P <0.05)。死亡组血清PTX3、Sestrin2水平均高于存活组(P <0.05)。ROC曲线结果分析显示,PTX3联合Sestrin2预测感染性休克患者预后的曲线下面积(AUC)最大,为0.904(95%CI:0.853,0.955),特异性为85.68%(95%CI:0.838,0.948),敏感性为84.26%(95%CI:0.884,0.932)。死亡组年龄≥60岁占比、SOFA评分、...

关 键 词:感染性休克  正五聚蛋白3  Sestrin2  预后
收稿时间:2023-08-08

Predictive efficacy of serum PTX3 combined with Sestrin2 for disease outcome in patients with septic shock
Fu Qi-peng,Chen Yu,Zhang Jie,Liang Shi-guo. Predictive efficacy of serum PTX3 combined with Sestrin2 for disease outcome in patients with septic shock[J]. China Journal of Modern Medicine, 2024, 34(10): 78-83
Authors:Fu Qi-peng  Chen Yu  Zhang Jie  Liang Shi-guo
Affiliation:Department of Emergency, Haikou People''s Hospital (Haikou Affiliated Hospital of Central South University Xiangya School of Medicine), Haikou, Hainan 570208, China
Abstract:Objective To explore the predictive efficacy of serum Pentraxin 3 (PTX3) combined with Sestrin2 for disease outcome in patients with septic shock.Methods A total of 122 patients with septic shock admitted to our hospital from May 2020 to May 2023 were selected as the study group, followed up for 28 days, and divided into survival group (n = 83) and death group (n = 39) according to the prognosis. In addition, 150 healthy people who underwent health checkup in our hospital during the same period were included as the control group. Serum levels of PTX3 and Sestrin2 were detected by enzyme-linked immunosorbent assay, and the predictive values of serum PTX3 and Sestrin2 for prognosis of patients with septic shock were assessed by receiver operating characteristic (ROC) curves. The factors affecting the prognosis of patients with septic shock were analyzed by multivariable stepwise Logistic regression.Results Serum levels of PTX3 and Sestrin2 in the study group were higher than those in the control group (P < 0.05). Serum levels of PTX3 and Sestrin2 in the death group were higher than those in the survival group (P < 0.05). ROC curve analysis showed that the area under the curve (AUC) of PTX3 combined with Sestrin2 for predicting the prognosis of patients with septic shock was the largest, which was 0.904 (95% CI: 0.853, 0.955), with a specificity of 85.68% (95% CI: 0.838, 0.948) and a sensitivity of 84.26% (95% CI: 0.884, 0.932). The proportion of patients with the age ≥ 60 years, SOFA score and APACHEⅡ score in the death group were higher than those in the survival group (P < 0.05), and the leukocyte count and serum levels of creatinine and procalcitonin in the death group were higher than those in the survival group (P < 0.05). The multivariable stepwise Logistic regression analysis (inclusion of variables with α < 0.05 and exclusion of variables with α > 0.10) revealed that high SOFA score [O^R = 2.022 (95% CI: 1.443, 2.832) ], high level of procalcitonin [O^R = 2.261 (95% CI: 1.577, 3.243) ], PTX3 ≥ 94.72 ng/mL [O^R = 3.019 (95% CI: 1.939, 4.702) ], and Sestrin2 ≥ 15.87 ng/mL [O^R = 2.617 (95% CI: 1.727, 3.965) ] were the prognostic factors for patients with septic shock (P < 0.05).Conclusion Serum PTX3 and Sestrin2 are highly expressed in patients with septic shock, and are biomarkers for predicting the prognosis of patients with septic shock, with the combination of the two indicators yielding higher predictive efficacy.
Keywords:septic shock  Pentraxin 3  Sestrin2  prognosis
点击此处可从《中国现代医学杂志》浏览原始摘要信息
点击此处可从《中国现代医学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号